Evidence map›Paper›PMID 35896299›Full record

ArticleBMJ open2022

Embryo selection through non-invasive preimplantation genetic testing with cell-free DNA in spent culture media: a protocol for a multicentre, double-blind, randomised controlled trial.

Jin Huang, Li Rong, Lin Zeng, Liang Hu, Juanzi Shi, Liyi Cai, Bing Yao, Xiu-Xia Wang, Yanwen Xu, Yuanqing Yao and 8 more

2 registry-linked trialsAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04339166 nacompletednot on this map

A Multicenter Clinical Study on Embryo Selection by Using the Ploidy of Cell Free DNA in Embryo Culture Medium

TypeinterventionalSponsorPeking University Third HospitalRan2020 to 2024Enrolled1,152ConditionsInfertility, Chromosome AbnormalityArmsNon-invasive chromosome screening(NICS)
NCT06084377 completednot on this map

Isolation of Extracellular Embryonic DNA FromIn Vitro Fertilization (IVF) Embryonic Culture Medium and Its Potential Role for Preimplantation Genetic Screening (PGS).

TypeobservationalSponsorDamascus UniversityRan2020 to 2023Enrolled27ConditionsFemales Undergoing PGD Technology for Medical ConditionsArmsPreimplantation Genetic Screening
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Genomic aspects in reproductive medicine.Clinical and experimental reproductive medicine · 2024
    Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jin Huang *Centre for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.ORCID 0000-0003-1879-4219
Li Rong *Centre for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
Lin ZengResearch Centre of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.ORCID 0000-0001-8707-5854
Liang HuInstitute of Reproductive and Stem Cell Engineering, NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Juanzi ShiNorthwest Women's and Children's Hospital, Xi'an, China.ORCID 0000-0002-9040-7829
Liyi CaiReproductive Medical Center of Hebei Maternity Hospital, Shijiazhuang, China.
Bing YaoAffiliated Jinling Hospital, Nanjing, China.
Xiu-Xia WangShengjing Hospital of China Medical University, Shenyang, China.
Yanwen XuCentre for Reproductive Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Yuanqing YaoDepartment of Obstetrics and Gynecology, Chinese People's Liberation Army General Hospital, Beijing, China.
Yan WangDepartment of Obstetrics and Gynecology, Sichuan University West China Second University Hospital, Chengdu, Sichuan, China.
Junzhao ZhaoDepartment of Obstetrics and Gynecology, Wenzhou Medical College Second Affiliated Hospital, Wenzhou, China.ORCID 0000-0002-2385-205X
Yichun GuanReproductive Medicine Center, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Weiping QianThe Center of Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
Guimin HaoSecond Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Sijia LuXukang Medical Technology (Suzhou) Co., Ltd, Suzhou, China.
Ping LiuCentre for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China Jie.qiao@263.net pingliu7703@sina.com.
Jie QiaoCentre for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China Jie.qiao@263.net pingliu7703@sina.com.ORCID 0000-0003-2126-1376

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMorphological evaluation is used to select embryos for in vitro fertilisation. However, it does not fully reflect the implantation potential. Preimplantation genetic testing for aneuploidies (PGT-A) can detect embryonic aneuploidy, but biopsy procedure is invasive. Currently, a non-invasive PGT (ni-PGT) approach using spent medium is being evaluated. However, the clinical benefit of ni-PGT has not been clearly demonstrated. A multicentre randomised trial is needed to verify whether ni-PGT can be an new effective tool for evaluating embryos. METHODS AND ANALYSIS: Overall, 1148 couples aged 35~42 (women) receiving in vitro fertilization-intracytoplasmic sperm injection are planned to be enrolled. Couples will be digitally randomised to (1) ni-PGT and (2) conventional morphology groups at a 1:1 treatment ratio. The primary outcome will be the ongoing pregnancy rate related to the first transfer cycle within 6 months after oocyte retrieval. ETHICS AND DISSEMINATION: The study protocol is approved by the Ethics Committee of Peking University Third Hospital and the participating hospitals. The results will be disseminated through international conferences and scientific journals. TRIAL REGISTRATION NUMBER: NCT04339166.

Indexed as

Cell-Free Nucleic AcidsPreimplantation DiagnosisAdultAneuploidyCulture MediaFemaleFertilization in VitroGenetic TestingHumansMaleMulticenter Studies as TopicPregnancyRandomized Controlled Trials as TopicSemenCell-Free Nucleic AcidsCulture Mediaantenatalembryologyprenatal diagnosis

Identifiers

PMID35896299
PMCPMC9335017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.